Cargando…
Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide
Previous studies have suggested that MHC class I molecules bind and present peptides to CTL in a manner that is analogous to the presentation of peptides by class II molecules to Th. Crystallographic studies of HLA-A2 have led to the assignment of a putative peptide binding site that is bordered by...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188996/ https://www.ncbi.nlm.nih.gov/pubmed/3261776 |
Ejemplares similares
-
Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site
Publicado: (1988) -
HLA-A2 subtypes are functionally distinct in peptide binding and presentation
Publicado: (1995) -
Prediction of HLA-A2 binding peptides using Bayesian network
por: Astakhov, Vadim, et al.
Publicado: (2005) -
“Human and Mouse Cross-Reactive” Albumin-Binding
Helix–Loop–Helix Peptide Tag for Prolonged Bioactivity
of Therapeutic Proteins
por: Nakatani, Yuto, et al.
Publicado: (2022) -
T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations
por: Nersisyan, Stepan, et al.
Publicado: (2021)